These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37801493)

  • 1. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets.
    Su GH; Xiao Y; You C; Zheng RC; Zhao S; Sun SY; Zhou JY; Lin LY; Wang H; Shao ZM; Gu YJ; Jiang YZ
    Sci Adv; 2023 Oct; 9(40):eadf0837. PubMed ID: 37801493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
    Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
    Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.
    Jiang YZ; Ma D; Jin X; Xiao Y; Yu Y; Shi J; Zhou YF; Fu T; Lin CJ; Dai LJ; Liu CL; Zhao S; Su GH; Hou W; Liu Y; Chen Q; Yang J; Zhang N; Zhang WJ; Liu W; Ge W; Yang WT; You C; Gu Y; Kaklamani V; Bertucci F; Verschraegen C; Daemen A; Shah NM; Wang T; Guo T; Shi L; Perou CM; Zheng Y; Huang W; Shao ZM
    Nat Cancer; 2024 Apr; 5(4):673-690. PubMed ID: 38347143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
    Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
    Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
    Saeki S; Kumegawa K; Takahashi Y; Yang L; Osako T; Yasen M; Otsuji K; Miyata K; Yamakawa K; Suzuka J; Sakimoto Y; Ozaki Y; Takano T; Sano T; Noda T; Ohno S; Yao R; Ueno T; Maruyama R
    Breast Cancer Res; 2023 Feb; 25(1):21. PubMed ID: 36810117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiogenomic analysis of cellular tumor-stroma heterogeneity as a prognostic predictor in breast cancer.
    Fan M; Wang K; Zhang Y; Ge Y; Lü Z; Li L
    J Transl Med; 2023 Nov; 21(1):851. PubMed ID: 38007511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
    Ai H; Song D; Wang X
    Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis.
    Kang W; Qiu X; Luo Y; Luo J; Liu Y; Xi J; Li X; Yang Z
    J Transl Med; 2023 Sep; 21(1):598. PubMed ID: 37674169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer.
    Jiang L; You C; Xiao Y; Wang H; Su GH; Xia BQ; Zheng RC; Zhang DD; Jiang YZ; Gu YJ; Shao ZM
    Cell Rep Med; 2022 Jul; 3(7):100694. PubMed ID: 35858585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Shi Z; Huang X; Cheng Z; Xu Z; Lin H; Liu C; Chen X; Liu C; Liang C; Lu C; Cui Y; Han C; Qu J; Shen J; Liu Z
    Radiology; 2023 Jul; 308(1):e222830. PubMed ID: 37432083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer.
    Fan M; Xia P; Clarke R; Wang Y; Li L
    Nat Commun; 2020 Sep; 11(1):4861. PubMed ID: 32978398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer.
    Marisa L; Blum Y; Taieb J; Ayadi M; Pilati C; Le Malicot K; Lepage C; Salazar R; Aust D; Duval A; Blons H; Taly V; Gentien D; Rapinat A; Selves J; Mouillet-Richard S; Boige V; Emile JF; de Reyniès A; Laurent-Puig P
    Clin Cancer Res; 2021 Sep; 27(17):4768-4780. PubMed ID: 34168047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomic Analysis of Breast Cancer by Using B-Mode and Vascular US and RNA Sequencing.
    Park AY; Han MR; Park KH; Kim JS; Son GS; Lee HY; Chang YW; Park EK; Cha SH; Cho Y; Hong H; Cho KR; Song SE; Woo OH; Lee JH; Cha J; Seo BK
    Radiology; 2020 Apr; 295(1):24-34. PubMed ID: 32013793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
    Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
    Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
    Yamamoto S; Han W; Kim Y; Du L; Jamshidi N; Huang D; Kim JH; Kuo MD
    Radiology; 2015 May; 275(2):384-92. PubMed ID: 25734557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
    Arefan D; Hausler RM; Sumkin JH; Sun M; Wu S
    BMC Cancer; 2021 Apr; 21(1):370. PubMed ID: 33827490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiomics model development via the associations with genomics features in predicting axillary lymph node metastasis of breast cancer: a study based on a public database and single-centre verification.
    Chen H; Wang X; Lan X; Yu T; Li L; Tang S; Liu S; Jiang F; Wang L; Zhang J
    Clin Radiol; 2023 Mar; 78(3):e279-e287. PubMed ID: 36623978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
    Li L; Chen C; Wang X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.